2006 annual financial data

BioCryst Pharmaceuticals 2006 Operating margin

BioCryst Pharmaceuticals 2006 operating margin with verified reported values.

Direct answer

Operating margin was -756.28%.

Operating income was -46,979,809 USD and net income was -43,617,853 USD.
Operating cash flow was -15,211,315 USD.

Get free BioCryst Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
6,211,936 USD
Operating income
-46,979,809 USD
Net income
-43,617,853 USD
Operating cash flow
-15,211,315 USD